Julia Fürst

809 total citations · 1 hit paper
15 papers, 500 citations indexed

About

Julia Fürst is a scholar working on Infectious Diseases, Epidemiology and Physiology. According to data from OpenAlex, Julia Fürst has authored 15 papers receiving a total of 500 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Infectious Diseases, 4 papers in Epidemiology and 4 papers in Physiology. Recurrent topics in Julia Fürst's work include COVID-19 Clinical Research Studies (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Allergic Rhinitis and Sensitization (3 papers). Julia Fürst is often cited by papers focused on COVID-19 Clinical Research Studies (4 papers), SARS-CoV-2 and COVID-19 Research (3 papers) and Allergic Rhinitis and Sensitization (3 papers). Julia Fürst collaborates with scholars based in Germany, France and Switzerland. Julia Fürst's co-authors include Bettina Hohberger, Gerd Wallukat, Johannes Müller, Katrin Wenzel, Sarah Schulze-Rothe, Martin Herrmann, Jakob Hoffmanns, Markéta Kubánková, Jochen Guck and Martin Kräter and has published in prestigious journals such as Biophysical Journal, Journal of Allergy and Clinical Immunology and Antimicrobial Agents and Chemotherapy.

In The Last Decade

Julia Fürst

15 papers receiving 484 citations

Hit Papers

Functional autoantibodies against G-protein coupled recep... 2021 2026 2022 2024 2021 50 100 150 200

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julia Fürst Germany 7 251 209 78 68 57 15 500
E. Kinnunen Finland 17 410 1.6× 150 0.7× 46 0.6× 98 1.4× 21 0.4× 37 928
Yuming Huang China 12 61 0.2× 50 0.2× 58 0.7× 38 0.6× 40 0.7× 48 392
Hiroyuki Torisu Japan 17 143 0.6× 150 0.7× 59 0.8× 193 2.8× 44 0.8× 57 804
Anelia Dietmann Austria 15 194 0.8× 128 0.6× 24 0.3× 113 1.7× 49 0.9× 41 650
Yoshito Ishizaki Japan 15 129 0.5× 88 0.4× 51 0.7× 278 4.1× 49 0.9× 38 788
Mark Ellul United Kingdom 12 340 1.4× 256 1.2× 15 0.2× 47 0.7× 8 0.1× 25 661
Shitiz Sriwastava United States 16 480 1.9× 262 1.3× 24 0.3× 60 0.9× 27 0.5× 60 728
Johan Lundberg Sweden 12 152 0.6× 89 0.4× 19 0.2× 88 1.3× 46 0.8× 30 453
R Dubs Switzerland 11 196 0.8× 120 0.6× 46 0.6× 206 3.0× 37 0.6× 14 770
Satoshi Kataoka Japan 14 152 0.6× 82 0.4× 30 0.4× 113 1.7× 101 1.8× 45 684

Countries citing papers authored by Julia Fürst

Since Specialization
Citations

This map shows the geographic impact of Julia Fürst's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julia Fürst with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julia Fürst more than expected).

Fields of papers citing papers by Julia Fürst

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julia Fürst. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julia Fürst. The network helps show where Julia Fürst may publish in the future.

Co-authorship network of co-authors of Julia Fürst

This figure shows the co-authorship network connecting the top 25 collaborators of Julia Fürst. A scholar is included among the top collaborators of Julia Fürst based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julia Fürst. Julia Fürst is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

15 of 15 papers shown
1.
Steininger, Philipp, Karl Bihlmaier, Julia Fürst, et al.. (2025). Metagenomic analysis of microbial cell-free DNA from plasma of patients with suspected infections: performance and therapeutic impact in clinical routine. Clinical Microbiology and Infection. 31(6). 1018–1025. 2 indexed citations
2.
Mair, Maximilian J., Angelika M. Starzer, Julia Fürst, et al.. (2023). 2115P Pre-cachexia incidence in patients with solid cancer: A cross-sectional study. Annals of Oncology. 34. S1107–S1107. 3 indexed citations
3.
Mihai, Sidonia, Richard Strauß, Ixchel Castellanos, et al.. (2023). β-(1→3)-D-glucan- and mannan-guided early termination of antifungal therapy in ICU patients: a randomized controlled study. Antimicrobial Agents and Chemotherapy. 67(11). e0072523–e0072523. 2 indexed citations
4.
Fürst, Julia, Kurt Bollmann, Martin M. Goßner, Peter Duelli, & Martin К. Obrist. (2022). Increased arthropod biomass, abundance and species richness in an agricultural landscape after 32 years. Journal of Insect Conservation. 27(2). 219–232. 8 indexed citations
5.
Zundler, Sebastian, Christian Y. Mardin, Simone Bertz, et al.. (2022). Rectal Cancer Presenting with Absceding Infection Due to Fusobacterium nucleatum. Pathogens. 11(10). 1113–1113. 2 indexed citations
6.
Wacker, Jochen, et al.. (2022). Clinical Images: Voriconazole‐induced synovitis, enthesitis, and periostitis. Arthritis & Rheumatology. 74(7). 1183–1183. 1 indexed citations
7.
Dugas, Martin, Uta Merle, Michaëla Fontenay, et al.. (2021). Lack of antibodies against seasonal coronavirus OC43 nucleocapsid protein identifies patients at risk of critical COVID-19. Journal of Clinical Virology. 139. 104847–104847. 31 indexed citations
8.
Wallukat, Gerd, Bettina Hohberger, Katrin Wenzel, et al.. (2021). Functional autoantibodies against G-protein coupled receptors in patients with persistent Long-COVID-19 symptoms. Journal of Translational Autoimmunity. 4. 100100–100100. 227 indexed citations breakdown →
9.
Hohberger, Bettina, Marion Ganslmayer, Marianna Lucio, et al.. (2021). Retinal Microcirculation as a Correlate of a Systemic Capillary Impairment After Severe Acute Respiratory Syndrome Coronavirus 2 Infection. Frontiers in Medicine. 8. 676554–676554. 24 indexed citations
10.
Kubánková, Markéta, Bettina Hohberger, Jakob Hoffmanns, et al.. (2021). Physical phenotype of blood cells is altered in COVID-19. Biophysical Journal. 120(14). 2838–2847. 133 indexed citations
11.
Knopf, Jasmin, Aylin Lindemann, Julia Fürst, et al.. (2020). IgA2 Antibodies against SARS-CoV-2 Correlate with NET Formation and Fatal Outcome in Severely Diseased COVID-19 Patients. Cells. 9(12). 2676–2676. 28 indexed citations
12.
Dockhorn, Robert J., Sherwin A. Gillman, Gil J. Gross, et al.. (1996). A comparison of effects of triamcinolone acetonide aqueous nasal spray, oral prednisone, and placebo on adrenocortical function in male patients with allergic rhinitis. Journal of Allergy and Clinical Immunology. 98(1). 32–38. 29 indexed citations
13.
Schenkel, Eric, Gary N. Gross, Bob Lanier, et al.. (1996). 61 Triamcinolone acetonide aqueous nasal spray does not alter adrenocortical function in children with allergic rhinitis. Journal of Allergy and Clinical Immunology. 97(1). 198–198. 3 indexed citations
14.
LaForce, Craig, Frank C. Hampel, William R. Lumry, et al.. (1996). 1002 Comparison of once-daily triamcinolone acetonide aqueous nasal spray and twice-daily beconase AQ® for the treatment of seasonal allergic rhinitis due to ragweed. Journal of Allergy and Clinical Immunology. 97(1). 433–433. 4 indexed citations
15.
Schenkel, Eric, Gary N. Gross, Kraig W. Jacobson, et al.. (1996). 60 Efficacy and safety of once-daily triamcinolone acetonide aqueous nasal spray in pediatric patients with spring grass seasonal allergic rhinitis. Journal of Allergy and Clinical Immunology. 97(1). 197–197. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026